Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Brian Burkavage Insider Profile
4 Followers
Brian Burkavage, CAO at IO Biotech, holds 11.50K shares in IO Biotech (Ticker: IOBT). Most recently, Brian Burkavage Bought $10,000 shares of IO Biotech on Nov 24, 2023 for an estimated value of 10.10K.
Brian Burkavage has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Brian Burkavage's holdings
Insider Roles
CAO
Roles that Brian Burkavage holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Brian Burkavage
Brian Burkavage's Trading History
List of latest transactions for each holding click on a transaction to see Brian Burkavage's performance on stock
You May Also Like
Brian Burkavage insider profile FAQ
What is the percentage of profitable transactions made by Brian Burkavage?
The percentage of profitable transactions made by Brian Burkavage is ―.
What is the average return per transaction made by Brian Burkavage?
The average return per transaction made by Brian Burkavage is ―.
What stocks does Brian Burkavage hold?
Brian Burkavage holds: IOBT stocks.
What was Brian Burkavage’s latest transaction?
Brian Burkavage latest transaction was an Informative Buy of $10.10K.
What was Brian Burkavage's most profitable transaction?
Brian Burkavage’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Brian Burkavage's role in IO Biotech?
Brian Burkavage's role in IO Biotech is CAO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.